Cagan McAfee Capital Partners teams with Myles Sherman to Acquire Minimally Invasive Devices
Aug 21, 2017 10:11 am UTC| Business
CUPERTINO, Calif., Aug. 21, 2017 -- Cagan McAfee Capital Partners and seasoned investor/operator, Myles Sherman of Austin, TX, have teamed up to acquire Minimally Invasive Devices (MID). Laird Cagan, will be...
Nidec to Acquire SV Probe Pte. Ltd., a Probe Card Manufacturer
Aug 21, 2017 10:04 am UTC| Business
KYOTO, Japan, Aug. 21, 2017 -- Nidec Corporation (TSE:6594) (OTC US:NJDCY) (the “Company” or “Nidec”) today announced that the Company has agreed to acquire 100% equity shares of SV Probe Pte. Ltd. (“SV Probe”), a probe...
CytoDyn Provides Update on PRO 140 Pivotal Combination Therapy Trial in Patients with HIV
Aug 21, 2017 10:00 am UTC| Business
VANCOUVER, Washington, Aug. 21, 2017 -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company focused on the development of new antibody therapies for combating human immunodeficiency virus (HIV) infection, announces that...
Aug 21, 2017 10:00 am UTC| Business
SAN DIEGO, Aug. 21, 2017 -- MatriSys Bioscience, a leader in the field of microbiome-based therapeutics for the treatment of skin conditions, today announced that the first patient has been dosed in a Phase 2A clinical...
Aug 21, 2017 10:00 am UTC| Business
CHICAGO, Aug. 21, 2017 -- TransUnion (NYSE:TRU) today announced that it has appointed the honorable Katharina McFarland to its Government Advisory Board. The Advisory Board provides TransUnion with valuable perspective...
Aug 21, 2017 10:00 am UTC| Business
EDISON, N.J., Aug. 21, 2017 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the United...
Aug 21, 2017 09:33 am UTC| Business
LONDON, Aug. 21, 2017 -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases,...